ABL Bio is a leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. ABL Bio owns a productive set of innovative bispecific antibody platforms and pipelines. In the neurodegenerative disorder space, ABL Bio develops potential therapeutics for CNS-related disea…